With the opioid crisis harming families and communities, IHA supports efforts to limit access to those powerful painkillers, coordinate response among providers and encourage individual recovery.
HRSA has launched an effort to improve access to substance use disorder treatment, HRSA DATA 2000 Waiver Training Payment Program for Buprenorphine-Trained Clinicians.
Today, President Donald Trump signed the bipartisan SUPPORT for Patients and Communities Act, H.R. 6 (115).
This memo summarizes legislation passed by the U.S. House to address the opioid crisis.
IHA collaborated with the Illinois College of Emergency Physicians (ICEP) to develop informational guidelines for treating patients with acute and chronic pain in the emergency department (ED).
IHA and ICEP’s informational guidelines on treating patients with acute and chronic pain in the ED are also available in an executive summary. Both versions address common clinical scenarios.
Illinois' Naloxone Standing Order acts as a prescription and allows pharmacists, pharmacies, and opioid overdose education and naloxone distribution programs to obtain and/or distribute naloxone.
In March 2016, the Centers for Disease Control and Prevention issued guidelines and recommendations on opioid use to treat chronic, non-cancer pain.
Effective Sept. 9, 2015, a landmark law in Illinois addresses opioid abuse and its illegal use by amending nearly 25 state laws, including the Hospital Licensing and Controlled Substance Act.